Complement Terminal Pathway Activation is Associated with Organ Failure in Sepsis Patients

被引:5
|
作者
Ahmad, Fatima M. [1 ,2 ]
Al-Binni, Maysaa' A. [2 ]
Hani, Amjad Bani [3 ]
Abu Abeeleh, Mahmoud [3 ]
Abu-Humaidan, Anas H. A. [1 ]
机构
[1] Univ Jordan, Sch Med, Dept Pathol Microbiol & Forens Med, Amman, Jordan
[2] Univ Jordan, Sch Sci, Dept Clin Lab Sci, Amman, Jordan
[3] Univ Jordan, Sch Med, Dept Gen Surg, Amman, Jordan
关键词
C5; C5b-9; CD59; Sequential Organ Failure Assessment; intensive care unit; MEMBRANE ATTACK; SEPTIC SHOCK; CD59; SYSTEM;
D O I
10.2147/JIR.S344282
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Complement plays a pivotal role in the immune response to infection. Several studies demonstrated complement activation in sepsis, yet little is known of the relationship of complement terminal pathway activation and the clinical characteristics of sepsis patients. Therefore, we investigated serum C5, soluble C5b-9 (sC5b-9), and soluble CD59 (sCD59) and their relation to organ failure in sepsis patients in the intensive care unit (ICU). Methods: In this prospective cohort study, all available patients admitted to the adult ICUs between June 2020 and January 2021 were included. Patients were divided into sepsis and non-sepsis groups according to the Sepsis-3 criteria, serum samples from both groups were investigated for the levels of C5, sC5b-9, and sCD59 using commercial sandwich ELISA kits. Results: We analyzed 79 serum samples, 36 were from sepsis patients. We found that sepsis patients had significantly lower C5 (83.6 +/- 28.4 vs 104.4 +/- 32.0 mu g/mL, p = 0.004) and higher sCD59 (380.7 +/- 170.5 vs 288.9 +/- 92.5 ng/mL, p = 0.016). sC5b-9, although higher in sepsis patients, did not reach statistical significance (1.5 +/- 0.8 mu g/mL vs 1.3 +/- 0.7 mu g/mL, p = 0.293). Sepsis patients who died during their ICU stay had significantly higher sCD59 compared to those who survived (437.0 +/- 176.7 vs 267.8 +/- 79.7 ng/mL, p = 0.003, respectively). Additionally, C5 and sCD59 both correlated to SOFA score in the sepsis group (r(s) = -0.44, P = 0.007 and = 0.43, P = 0.009, respectively), and a similar correlation was not found in the non-sepsis group. Discussion: In sepsis patients, levels of C5 and sCD59, but not sC5b-9, correlated to the severity of organ damage measured by SOFA. A similar correlation was not found in non-sepsis patients. This indicated that organ damage associated with sepsis led to a more pronounced terminal pathway activation than in non-sepsis patients, it also indicated the potential of using C5 and sCD59 to reflect sepsis severity.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 50 条
  • [1] The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure
    Holt, Margrethe Flesvig
    Michelsen, Annika E.
    Shahini, Negar
    Bjorkelund, Elisabeth
    Bendz, Christina Holt
    Massey, Richard J.
    Schjalm, Camilla
    Halvorsen, Bente
    Broch, Kaspar
    Ueland, Thor
    Gullestad, Lars
    Nilsson, Per H.
    Aukrust, Pal
    Mollnes, Tom Eirik
    Louwe, Mieke C.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] Complement activation as contributor and therapeutic target in sepsis-induced organ failure
    Lupu, Florea
    Coggeshall, Mark
    DeMarco, Steve
    Lambris, John D.
    [J]. MOLECULAR IMMUNOLOGY, 2015, 67 (01) : 157 - 158
  • [3] ACTIVATION OF THE HUMAN TERMINAL COMPLEMENT PATHWAY IN ATHEROSCLEROSIS
    NICULESCU, F
    RUS, HG
    VLAICU, R
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 45 (02): : 147 - 155
  • [4] PLATELET ACTIVATION AND INTERACTION WITH LEUKOCYTES IN PATIENTS WITH SEPSIS OR MULTIPLE ORGAN FAILURE
    GAWAZ, M
    FATEHMOGHADAM, S
    PILZ, G
    GURLAND, HJ
    WERDAN, K
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (11) : 843 - 851
  • [5] Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis
    Staels, F.
    Meersseman, W.
    Stordeur, P.
    Willekens, K.
    Van Loo, S.
    Corveleyn, A.
    Meyts, I.
    Meyfroidt, G.
    Schrijvers, R.
    [J]. CASE REPORTS IN IMMUNOLOGY, 2022, 2022
  • [6] Prevention of terminal pathway activation improves survival in a lethal malarial infection mouse model associated with multiple organ failure
    Mizuzo, Masashi
    Kamiya, Tomoaki
    Miyasaka, Yuki
    Kim, Hangsoo
    Fukui, Sosuke
    Ishigami, Masatoshi
    Suzuki, Yasuhiro
    Maruyama, Shoichi
    Ohno, Tamio
    Hughes, Timothy
    Morgan, B. Paul
    [J]. IMMUNOBIOLOGY, 2023, 228 (05) : 3 - 3
  • [7] ACTIVATION-DEPENDENT EPITOPES IN THE TERMINAL COMPLEMENT PATHWAY
    MOLLNES, TE
    LEA, T
    TSCHOPP, J
    [J]. COMPLEMENT AND INFLAMMATION, 1989, 6 (03) : 223 - 235
  • [8] QUANTITATION OF ACTIVATION OF THE HUMAN TERMINAL COMPLEMENT PATHWAY BY ELISA
    SANDERS, ME
    SCHMETZ, MA
    HAMMER, CH
    FRANK, MM
    JOINER, KA
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 85 (02) : 245 - 256
  • [9] Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis
    Marco Mannes
    Christoph Q. Schmidt
    Bo Nilsson
    Kristina N. Ekdahl
    Markus Huber-Lang
    [J]. Seminars in Immunopathology, 2021, 43 : 773 - 788
  • [10] Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis
    Mannes, Marco
    Schmidt, Christoph Q.
    Nilsson, Bo
    Ekdahl, Kristina N.
    Huber-Lang, Markus
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2021, 43 (06) : 773 - 788